Efficacy of osteopathic manipulative treatment in reducing monthly migraine days: a meta-analysis
Abstract
Context: Migraine is a highly prevalent and disabling neurological condition affecting approximately 12 % of adults in the United States, with substantial personal and economic burdens. Nonpharmacologic therapies, including osteopathic manipulative treatment (OMT), are increasingly utilized as adjunctive or alternative management strategies, yet the evidence base for OMT efficacy in migraine remains variable and incompletely synthesized.
Objectives: The objective of this study was to evaluate the efficacy of OMT in reducing monthly migraine days compared to control interventions in adult patients through a systematic review and meta-analysis of randomized controlled trials.
Methods: A comprehensive literature search was conducted across PubMed, Scopus, NIH Library, and Wiley Library through December 2024. Studies were included if they enrolled adult migraine patients, evaluated OMT for a minimum of 5 weeks, included a control group, and reported monthly migraine day outcomes. Five randomized controlled trials (n=258) met all of the inclusion criteria. Effect sizes were standardized to the mean difference in monthly migraine days; a fixed-effect model was applied to pool the results across studies.
Results: Pooled analysis demonstrated a statistically significant overall reduction of -0.38 monthly migraine days (95 % CI, -0.43 to -0.32) with OMT compared to the control interventions. Individual study effects ranged from -0.23 to -21.06 migraine days. Heterogeneity was extreme…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 258 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.